Dr. Michael H Gelb's lab at the University of Washington focuses on improving newborn screening for genetic diseases using advanced biochemical and molecular techniques. Their research aims to develop innovative methods to analyze DNA variants and protein mutations that could influence disease outcomes. This work could significantly enhance how newborns are screened for treatable conditions, leading to better health strategies and reduced anxiety for families.

Gabriele Varani's lab at the University of Washington focuses on understanding how small molecules interact with RNA. This research aims to develop new drugs that can target RNA viruses, such as Dengue and Zika, by designing molecules that bind to RNA with high specificity and affinity. The lab not only investigates the chemistry behind these interactions but also works on practical applications in fighting viral infections and addressing unmet medical needs.

Daniel T. Chiu's lab at the University of Washington focuses on developing innovative technologies to study gene expression in tissues and fetal health. They work on advanced imaging methods for analyzing tissues and biomarkers found in pregnant women, providing critical insights into conditions like neonatal abstinence syndrome. Their research combines chemistry and molecular biology techniques to enhance our understanding of complex biological systems.